Related Experiment Videos
Cancer genes and risk assessment
1Atomic Energy of Canada Limited, Radiation Biology and Health Physics Branch, Chalk River, Ontario.
Health Physics
|February 5, 1998
Summary
Cancer risk assessment must account for genetic predisposition alongside radiation exposure. Incorporating genetic and biological risk factors into models improves understanding of individual cancer susceptibility.
Area of Science:
- Radiation biology
- Genetics
- Cancer research
Background:
- Current radiation risk assessment models primarily focus on exposure as the sole risk factor for cancer induction.
- These models assume a probabilistic relationship between low-level radiation exposure and cancer, neglecting individual genetic predispositions.
- Genetic and biological factors significantly influence an individual's susceptibility to cancer, independent of environmental exposures.
Purpose of the Study:
- To develop and test a genetic cancer risk factors model for improved risk assessment.
- To integrate genetic and biological risk factors into existing radiation protection frameworks.
- To evaluate the impact of genetic predisposition on radiogenic cancer risk.
Main Methods:
- Surveyed the Online Mendelian Inheritance in Man (OMIM) database for genetic disorders associated with cancer.
- Determined gene map locations and collected DNA sequence information for identified genetic disorders.
- Analyzed molecular variants and population carrier frequencies of cancer risk genes.
Main Results:
- Identified 641 genetic disorders linked to cancer.
- Mapped 495 of these disorders to approximately 120 clusters on the human genome.
- Obtained partial DNA sequence data for 253 disorders, revealing molecular variants.
Conclusions:
- A significant portion of the population may carry genetic risk factors for cancer.
- Individual variability in radiogenic cancer risk due to genetic predisposition needs consideration in risk assessment models.
- Future models should integrate genetic and biological factors for more accurate cancer risk evaluation.